Literature DB >> 14576464

Identification and functional analysis of truncated human glutamic acid decarboxylase 65.

Jianning Wei1, Ying Jin, Heng Wu, Di Sha, Jang-Yen Wu.   

Abstract

Human brain glutamate decarboxylase 65 (hGAD65) was found to exist as full-length and truncated forms when the glutathione S-transferase-tagged hGAD65 fusion protein was subjected to factor Xa cleavage. The truncated form is produced by cleavage at arginine 69 based on N-terminal amino acid sequence analysis, and has a molecular weight of 58 kD. It is resistant to further factor Xa cleavage or mild trypsin treatment and is more active and more stable than the full-length form. Both the full-length and truncated forms of GAD are also observed in brain preparations in the presence of protease inhibitors. Furthermore, full-length GAD could be converted to the truncated form by endogenous proteases, suggesting that the conversion of full-length to truncated GAD mediated by endogenous protease may represent an important mechanism in the regulation of GABA biosynthesis in the brain. Copyright 2003 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576464     DOI: 10.1159/000073527

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  8 in total

1.  Glutamate decarboxylase: loss of N-terminal segment does not affect homodimerization and determination of the oxidation state of cysteine residues.

Authors:  Gino Battaglioli; Hongcheng Liu; Charles R Hauer; David L Martin
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

2.  Palmitoylation and trafficking of GAD65 are impaired in a cellular model of Huntington's disease.

Authors:  Daniel B Rush; Rebecca T Leon; Mark H McCollum; Ryan W Treu; Jianning Wei
Journal:  Biochem J       Date:  2012-02-15       Impact factor: 3.857

3.  Role of the proteasome in excitotoxicity-induced cleavage of glutamic acid decarboxylase in cultured hippocampal neurons.

Authors:  Márcio S Baptista; Carlos V Melo; Mário Armelão; Dennis Herrmann; Diogo O Pimentel; Graciano Leal; Margarida V Caldeira; Ben A Bahr; Mário Bengtson; Ramiro D Almeida; Carlos B Duarte
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

Review 4.  Post-translational regulation of L-glutamic acid decarboxylase in the brain.

Authors:  Jianning Wei; Jang-Yen Wu
Journal:  Neurochem Res       Date:  2008-02-13       Impact factor: 3.996

5.  Role of mu-calpain in proteolytic cleavage of brain L-glutamic acid decarboxylase.

Authors:  Di Sha; Ying Jin; Heng Wu; Jianning Wei; Chun-Hua Lin; Yi-Hsuan Lee; Chandana Buddhala; Shafi Kuchay; Athar H Chishti; Jang-Yen Wu
Journal:  Brain Res       Date:  2008-03-04       Impact factor: 3.252

Review 6.  Islet Autoantibodies.

Authors:  Vito Lampasona; Daniela Liberati
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

7.  Calpain cleavage of brain glutamic acid decarboxylase 65 is pathological and impairs GABA neurotransmission.

Authors:  Chandana Buddhala; Marjorie Suarez; Jigar Modi; Howard Prentice; Zhiyuan Ma; Rui Tao; Jang Yen Wu
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

8.  Analysis of Brain Protein Stability Changes in Mouse Models of Normal Aging and α-Synucleinopathy Reveals Age- and Disease-Related Differences.

Authors:  Renze Ma; Julia H R Johnson; Yun Tang; Michael C Fitzgerald
Journal:  J Proteome Res       Date:  2021-10-04       Impact factor: 5.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.